HIV treatment bulletin

RSS Atom • ISSN 1472-4683 • Subscribe • About

46th Interscience Conference on Antiretroviral Agents and Chemotherapy (ICAAC), 27-30 September 2006, San Francisco

• 46th Interscience Conference on Antiretroviral Agents and Chemotherapy (ICAAC), 27-30 September 2006, San Francisco Conference reports - Conference index - ICAAC 46th San Francisco 2006 - 7 October 2006

• MK-0518 demonstrates potent efficacy in patients with triple-class resistant virus: 24 week results Conference reports - Resistance - ICAAC 46th San Francisco 2006 - 7 October 2006

• Lipid profile of integrase inhibitor MK-0518: 24 week results compared to efavirenz in treatment naive patients Antiretrovirals - Conference reports - ICAAC 46th San Francisco 2006 - 7 October 2006

• HIV may use different coreceptors in blood and brain Basic science and immunology - Conference reports - ICAAC 46th San Francisco 2006 - 7 October 2006

• Critical interactions between darunavir (TMC114), lopinavir, Viagra, and oral contraceptives Conference reports - PK and drug interactions - ICAAC 46th San Francisco 2006 - 7 October 2006

• NRTI elvucitabine active against HIV in a 7-day monotherapy study Antiretrovirals - Conference reports - ICAAC 46th San Francisco 2006 - 7 October 2006

• Efavirenz/tenofovir fails as 2-drug maintenance regimen Antiretrovirals - Conference reports - ICAAC 46th San Francisco 2006 - 7 October 2006

• Nucleoside inhibitor MK-0608 mediates suppression of HCV replication for >30 days in chronically infected chimpanzees Conference reports - Hepatitis coinfection - ICAAC 46th San Francisco 2006 - 7 October 2006